Tricuspid atresia surgery

Tricuspid atresia Microchapters
Home
Patient Information
Overview
Pathophysiology
Causes
Differentiating Tricuspid Atresia from other Disorders
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography
Cardiac Catheterization
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Special Scenarios
Pregnancy
Case Studies
Case #1
Tricuspid atresia surgery On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Tricuspid atresia surgery All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Tricuspid atresia surgery
CDC on Tricuspid atresia surgery
Tricuspid atresia surgery in the news
Blogs on Tricuspid atresia surgery
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Tricuspid atresia surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Keri Shafer, M.D. [2] Priyamvada Singh, MBBS [[3]]

Assistant Editor-In-Chief: Kristin Feeney, B.S. [[4]]

Surgery

ACC/AHA Guidelines - Recommendation for Surgical Options for Patients With Single Ventricle (DO NOT EDIT)

“

Class I Surgeons with training and expertise in congenital heart disease (CHD) should perform operations for single-ventricle anatomy or physiology. (Level of Evidence: C)

”

Surgical Interventions

There are a number of interventional methods to address a tricuspid atresia. These include:

• PGE1 to maintain patent ductus arteriosus
• Modified Blalock-Taussig shunt to maintain pulmonary blood flow by placing a Gortex conduit between the subclavian artery and the pulmonary artery.
• Cavopulmonary anastomosis (hemi-Fontan or bidirectional Glenn) to provide stable pulmonary flow
• Fontan procedure to redirect inferior vena cava and hepatic vein flow into the pulmonary circulation

ACC/AHA Guidelines - Recommendation for Evaluation and Follow-Up After Fontan Procedure (DO NOT EDIT)

“

Class I Lifelong follow-up is recommended for patients after a Fontan type of operation; this should include a yearly evaluation by a cardiologist with expertise in the care of adult congenital heart disease (ACHD) patients. (Level of Evidence: C)

”

ACC/AHA Guidelines - Recommendations for Surgery for Adults with Prior Fontan Repair (DO NOT EDIT)

“

Class I Surgeons with training and expertise in CHD should perform operations on patients with prior Fontan repair for single-ventricle physiology. (Level of Evidence: C) Reoperation after Fontan is indicated for the following: Unintended residual atrial septal defect (ASD) that results in right-to-left shunt with symptoms and/or cyanosis not amenable to transcatheter closure. (Level of Evidence: C) Hemodynamically significant residual systemic artery-to-pulmonary artery shunt, residual surgical shunt, or residual ventricle-to-pulmonary artery connection not amenable to transcatheter closure. (Level of Evidence: C) Moderate to severe systemic atrioventricular (AV) valve regurgitation. (Level of Evidence: C) Significant (greater than 30-mm Hg peak-to-peak) subaortic obstruction. (Level of Evidence: C) Fontan pathway obstruction. (Level of Evidence: C) Development of venous collateral channels or pulmonary arteriovenous malformation not amenable to transcatheter management. (Level of Evidence: C) Pulmonary venous obstruction. (Level of Evidence: C) Rhythm abnormalities, such as complete AV block or sick sinus syndrome, that require epicardial pacemaker insertion. (Level of Evidence: C) Creation or closure of a fenestration not amenable to transcatheter intervention. (Level of Evidence: C) Class IIa Reoperation for Fontan conversion (i.e., revision of an atriopulmonary connection to an intracardiac lateral tunnel, intra-atrial conduit, or extracardiac conduit) can be useful for recurrent atrial fibrillation or flutter without hemodynamically significant anatomic abnormalities. A concomitant Maze procedure should also be performed. (Level of Evidence: C) Class IIb Heart transplantation may be beneficial for severe SV dysfunction or protein-losing enteropathy (PLE). (Level of Evidence: C)

”